Compared to Estimates, Integra (IART) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Integra (IART) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Integra LifeSciences (IART) Q2 Earnings and Revenues Surpass Estimates
Integra LifeSciences (IART) came out with quarterly earnings of $0.63 per share, beating the Zacks Consensus Estimate of $0.62 per share. This compares to earnings of $0.71 per share a year ago.
Earnings Preview: Integra LifeSciences (IART) Q2 Earnings Expected to Decline
Integra (IART) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Integra's (IART) New Site to Produce Recalled Tissue Products
Integra (IART) is set to recommence the manufacturing of PriMatrix and SurgiMend at its new facility in Braintree, MA.
Why Is Integra (IART) Up 26% Since Last Earnings Report?
Integra (IART) reported earnings 30 days ago. What's next for the stock?
Is The Options Market Predicting A Spike In Integra LifeScience (IART) Stock?
Investors need to pay close attention to Integra LifeScience (IART) stock based on the movements in the options market lately.
